Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1
Arnaud Bayle, Mohamed Khettab, Francesca Lucibello, Ali N. Chamseddine, Vincent Goldschmidt, Audrey Perret, Stanislas Ropert, Florian Scotté, Pierre Loulergue, Olivier Mir
Topics & Concepts
MedicineImmunogenicityVaccinationCancerInternal medicinePopulationOncologyInfluenza vaccineImmunologyImmune systemEnvironmental healthCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies